Tumor analysis highlighted germline variation in HR-related repair genes, particularly BRCA1, PALB2 and RAD51C, to have a potential driver role in EC development based on the presence of mutational signature indicative of HR deficiency. The gene discussed is PALB2; the disease is neoplasm.